Employees Retirement System of Texas’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-31
Closed -$81K – 1096
2018
Q2
$81K Hold
31
– – ﹤0.01% 1065
2018
Q1
$73K Hold
31
– – ﹤0.01% 1035
2017
Q4
$124K Hold
31
– – ﹤0.01% 1025
2017
Q3
$127K Hold
31
– – ﹤0.01% 1004
2017
Q2
$140K Hold
31
– – ﹤0.01% 999
2017
Q1
$167K Hold
31
– – ﹤0.01% 1010
2016
Q4
$137K Hold
31
– – ﹤0.01% 1004
2016
Q3
$644K Buy
31
+12
+63% +$217K 0.01% 874
2016
Q2
$287K Hold
19
– – ﹤0.01% 915
2016
Q1
$520K Hold
19
– – 0.01% 878
2015
Q4
$539K Buy
19
+8
+73% +$264K 0.01% 863
2015
Q3
$280K Buy
11
+2
+22% +$135K ﹤0.01% 907
2015
Q2
$752K Buy
+9
New +$824K 0.01% 823

Other funds holding TPST

Employees Retirement System of Texas's TPST Position: Q3 2018 in Review

Employees Retirement System of Texas sold out of Tempest Therapeutics (TPST) in Q3 2018, closing a stake of 31 shares — an estimated $81K sold.

Employees Retirement System of Texas first reported a position in TPST in Q2 2015 and held it in 13 quarters. The position peaked at $752K in Q2 2015. 35 funds tracked by Wall St. Rank hold TPST as of Q3 2018.

  • Employees Retirement System of Texas reported no remaining Tempest Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Employees Retirement System of Texas sold 31 Tempest Therapeutics shares in Q3 2018, an estimated $81K.
  • Employees Retirement System of Texas first reported a position in Tempest Therapeutics in Q2 2015 and held it in 13 quarters.
  • Employees Retirement System of Texas's Tempest Therapeutics position peaked at $752K in Q2 2015.
  • 35 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2018.

Based on Employees Retirement System of Texas's 13F filing for Q3 2018, filed 13 Nov 2018.